enGene Therapeutics Inc. (ENGN) stock
ENGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends October 31Also trades as ENGNW
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Jul 31, 2026Last filing: 10-Q on Sep 8, 2026Score 3/30
$1.85+0.13 (+7.56%)
Close on Nov 18, 2026Market cap $123.98MP/E –Yield 0.00%
enGene Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
enGene Therapeutics's market cap was $120.63M on Nov 11, 2026, against $412.42M a year earlier. Over the last 4 years it ranged from $5.10M to $525.91M, with a median of $211.05M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $120.63M | -74.3% |
| 2025 | Dec 31, 2025 | $469.73M | +38.6% |
| 2024 | Dec 31, 2024 | $338.99M | +58.3% |
| 2023 | Dec 29, 2023 | $214.12M | +3013.4% |
| 2022 | Dec 30, 2022 | $6.88M | – |
See a number that looks wrong?